Biocomputing 2020 2019
DOI: 10.1142/9789811215636_0036
|View full text |Cite
|
Sign up to set email alerts
|

PathFlowAI: A High-Throughput Workflow for Preprocessing, Deep Learning and Interpretation in Digital Pathology

Abstract: The diagnosis of disease often requires analysis of a biopsy. Many diagnoses depend not only on the presence of certain features but on their location within the tissue. Recently, a number of deep learning diagnostic aids have been developed to classify digitized biopsy slides. Clinical workflows often involve processing of more than 500 slides per day. But, clinical use of deep learning diagnostic aids would require a preprocessing workflow that is cost-effective, flexible, scalable, rapid, interpretable, and… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
17
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 22 publications
0
17
0
Order By: Relevance
“…Samples were fixed and embedded in paraffin blocks and 5-micron sections were stained with H&E and trichrome. Slides were scanned using the Leica Aperio-AT2 (Leica Microsystems, Buffalo Grove, IL) scanner at ×20 magnification, stored in SVS image format (JPEG compression at 70% quality), from which they were extracted and converted to NPY (uncompressed unsigned 8bit RGB numpy array) format via our in house pipeline, PathFlowAI [18].…”
Section: Biopsy Collection and Digitizationmentioning
confidence: 99%
See 1 more Smart Citation
“…Samples were fixed and embedded in paraffin blocks and 5-micron sections were stained with H&E and trichrome. Slides were scanned using the Leica Aperio-AT2 (Leica Microsystems, Buffalo Grove, IL) scanner at ×20 magnification, stored in SVS image format (JPEG compression at 70% quality), from which they were extracted and converted to NPY (uncompressed unsigned 8bit RGB numpy array) format via our in house pipeline, PathFlowAI [18].…”
Section: Biopsy Collection and Digitizationmentioning
confidence: 99%
“…Deep learning approaches, heuristics that utilize artificial neural networks (ANN) and convolutional neural networks, circumvent this issue in that they are able to find important shapes and patterns for prediction without human specification by capturing and integrating low level features into higher level abstractions [16,17]. Given the advent of these powerful machine learning tools, the Department of Pathology and Laboratory Medicine at Dartmouth Hitchcock Medical Center (DHMC) has fully embraced digital pathology with the caveat that it must leverage advanced computational technologies to provide significant benefits over traditional glass slides [18][19][20]. To this end, we have been developing and validating various deep learning technologies in histopathology and designing them to clinical scale [18,[21][22][23][24][25][26].…”
Section: Introductionmentioning
confidence: 99%
“…Slides were scanned using the Leica Aperio-AT2 (Leica Microsystems, Buffalo Grove, IL) scanner at 20x magnification, stored in SVS image format, from which they were extracted and converted to NPY format via our in house pipeline, PathFlowAI. 18 We utilized 20 H&E/Trichrome WSI pairs for training the deep learning model. WSI are large images that can span hundreds of thousands of pixels in any given spatial dimension.…”
Section: Biopsy Collection and Digitizationmentioning
confidence: 99%
“…Given the advent of these powerful machine learning tools, the Department of Pathology and Laboratory Medicine at Dartmouth Hitchcock Medical Center (DHMC) has fully embraced digital pathology with the caveat that it must leverage advanced computational technologies to provide significant benefits over traditional glass slides. [18][19][20] To this end, we have been developing and validating various deep learning technologies in histopathology and designing them to clinical scale 18,[21][22][23][24][25] .…”
Section: Introductionmentioning
confidence: 99%
“…Many research groups are developing high-throughput clinical pipelines to take advantage of these healthcare technologies. Validating and scaling these technologies is essential for successful deployment 10 .…”
Section: Introductionmentioning
confidence: 99%